[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C@@H1][Branch2][Branch1][C][C@@H1][Branch2][Ring2][Ring1][C@H1][Branch1][Branch1][C@@H1][Ring1][Branch1][O][/C][=C][/C@H1][Branch2][Ring1][Branch1][C][O][C][=C][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][Branch1][C][F][Branch1][C][F][F][O][C][/C][=C][\\C][C][C][C][=Branch1][C][=O][O][O]"}, {"from": "gpt", "value": "The molecule is an organofluorine compound that is racemic prostaglandin F2alpha in which the pentyl group is replaced by a 3-(trifluoromethyl)phenoxymethyl group. A synthetic analogue of prostaglandin F2alpha, ophthalmic solutions of its isopropyl ester prodrug, travoprost, are used as a topical medication for controlling the progression of open-angle glaucoma and ocular hypertension, by reducing intraocular pressure. The isopropyl ester group of travoprost is hydrolysed to the biologically active free acid by esterases in the cornea. It has a role as an antiglaucoma drug, an antihypertensive agent, a prostaglandin receptor agonist, a female contraceptive drug and an abortifacient. It is a prostaglandins Falpha, a hydroxy monocarboxylic acid and a member of (trifluoromethyl)benzenes."}]